Last edition
News about "Gastro-Enteropancreatic Neuroendocrine Tumours"
Amneal Launches FDA-Approved Lanreotide Injection in the US
Amneal Pharmaceuticals has launched lanreotide injection in the US following FDA approval, expanding its complex injectable medicines portfolio.
Gastro-Enteropancreatic Neuroendocrine Tumours | 28/09/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members